OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
The commission approved future plans, appointed members, and adopted texts during its November 2016 session.
The European Pharmacopoeia Commission
on Nov. 29, 2016 that, during its 156th session, the commission approved its working program activities until November 2019, which include actively involving observers and reviewing current processes and procedures. The commission also adopted 14 new texts and appointed chairpersons and members during the session.
New and revised texts that were adopted at the session will become effective January 1, 2018 and will be published in supplement 9.3 of the European Pharmacopoeia. The following texts were adopted:
Also adopted were 52 revised monographs, including eight dosage form monographs and 11 revised general chapters. The commission also revised its implementation strategy for the International Council for Harmonization (ICH) Q3D guideline on elemental impurities during the session.